Playback speed
10 seconds
CASPIAN Trial: Clinical Implications of a 3-Year OS Update of Durvalumab +/- Tremelimumab + Platinum-Etoposide in 1L Treatment of ES-SCLC
360 views
January 29, 2024
Login to view comments.
Click here to Login